Today

Agents

Chat

Arena

Discover

More

App

Denali Therapeutics Inc.: Morgan Stanley cuts target price to $37 from $42

DNLI•2026-11-13

Morgan Stanley cut its price target for Denali Therapeutics to $37 from $42.

Related News

A

AIRO Group signs at-the-market equity sales agreement with Cantor Fitzgerald

AIRO•2026-11-13

China's October new bank loans shrink for third time this year as credit demand weakens

SPY•2026-11-13

Prudential cuts indirect stake in Ranhill Utilities to 6.161%

PUK•2026-11-13

EMA's CHMP recommends indication extensions for Bexsero and Talzenna

GSK•2026-11-13

Dollar set for best week in two months as yen tests 160

TLT•2026-11-13

Denali Therapeutics Inc.: Morgan Stanley cuts target price to $37 from $42 - DNLI News | Rallies